MBL Venture Capital

MBL Venture Capital, also known as mblVC, is a venture capital firm founded in 2000. The firm is a subsidiary of Medical & Biological Laboratories Co., Ltd., a Japanese company that specializes in the research and manufacture of in-vitro diagnostics (IVDs) and research reagents. mblVC is primarily based in Tokyo, JapanJapan although it also has an additional office in Nagoya, Japan. The firm’s most recent investment is in Sentien Biotechnologies during September 2018, a company developing blood conditioning therapies for patients with critical illnesses.